Refrences
- Achur RN, Freeman WM, Vrana KE. (2010). Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol, 5(1), 83–91.
- Ahn YK, Kim JH. (1993). Preventiveeffectsofdiphenyl dimethyl dicarboxylate on the immunotoxicity of carbon tetrachloride in ICR mice. J Toxicol Sci, 18(3), 185–95.
- Ballas ZK, Cook RT, Shey MR, Coleman RA. (2013). A dynamic flux in natural killer cell subsets as a function of the duration of alcohol ingestion. Alcohol Clin Exp Res, 36(5), 826–34.
- Breitkopf K, Haas S, Wiercinska E, et al. (2005). Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res, 29, 121S–31S. doi:10.1097/01.alc.0000189284.98684.22.
- Cengiz N, Kavak S, Güzel A, et al. (2013). Investigation of the hepatoprotective effects of sesame (Sesamum indicum L) in carbon tetrachloride-induced liver toxicity. J Membr Biol, 246, 1–6.
- de Azevedo MT, Saad ST, Gilli SC. (2013). IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs. Immunol Invest, 42(8), 711–25.
- Delaney B, Strom SC, Collins S, Kaminski NE. (1994). Carbon tetrachloride suppresses T-cell-dependent immune responses by induction of transforming growth factor-β1. Toxicol Appl Pharmacol, 126(1), 98–107.
- Durum SK, Schmidt JA, Oppenheim JJ. (1985). Interleukin 1: An immunological perspective. Annu Rev Immunol, 3, 263–87.
- Friedman SL. (2008a). Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 88, 125–72. doi:10.1152/physrev.00013.2007.
- Friedman SL. (2008b). Mechanisms of hepatic fibrogenesis. Gastroenterology, 134(6), 1655–69.
- Friedman SL. (2010). Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol, 7, 425–36.
- Gäbele E, Brenner DA, Rippe RA. (2003). Liverfibrosis: Signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci, 8, d69–77.
- Ishiyama H, Sato M, Matsumura K, et al. (1995). Proliferation of hepatocytes and attenuation from carbon tetrachloride hepatotoxicity by gadolinium chloride in rats. Pharmacol Toxicol, 77(4), 293–8.
- Kawada N. (2011). Evolution of hepatic fibrosis research. Hepatol Res Off J Jpn Soc Hepatol 41, 199–208. doi:10.1111/j.1872-034X.2011.00776.x.
- Kim ME, Jung YC, Jung I, et al. (2015). Anti-inflammatory effects of ethanolic extract from Sargassum horneri (Turner) C. Agardh on lipopolysaccharide-stimulated macrophage activation via NF-κB pathway regulation. Immunol Invest, 44(2), 137–46.
- Laskin DL, Pendino KJ. (1995). Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol, 35, 655–77.
- Lee UE, Friedman SL. (2011). Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol, 25(2), 195–206.
- Liu MJ, Wang Z, Ju Y, et al. (2004). The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines. Biol Pharm Bull, 27, 1059–65.
- Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest, 86(5), 1641–8.
- Montgomery Bissell D, Gores GJ, Laskin DL, Hoofnagle JH. (2001). Drug-induced liver injury: Mechanisms and test systems. Hepatology, 33(4), 1009–13.
- Pinto C, Duque AL, Rodríguez-Galdón B, et al. (2012). Xanthohumol prevents carbon tetrachloride-induced acute liver injury in rats. Food Chem Toxicol, 50, 3405–12.
- Preethi KC, Kuttan R. (2009). Hepato and reno protective action of Calendula officinalis L flower extract. Indian J Exp Biol, 47, 163–8.
- Pritchard MT, Cohen JI, Roychowdhury S, et al. (2010). Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J Hepatol, 53(4), 655–62.
- Rocha SWS, Silva BS, Gomesetal FODS. (2012). Effect of diethylcarbamazine on chronic hepatic inflammation induced by alcohol in C57BL/6 mice. Eur J Pharmacol, 689(1–3), 194–203.
- Rockey DC. (2008). Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis, 12(4), 939–62.
- Seki E, de Minicis S, Inokuchi S, et al. (2009). CCR2 promotes hepatic fibrosis in mice. Hepatology, 50(1), 185–97.
- Shi X, Qian T, Li M, et al. (2015). Aberrant low expression of A20 in tumor necrosis factor-α-stimulated SLE monocytes mediates sustained NF-κB inflammatory response. Immunol Invest, 44(5), 497–508.
- Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, et al. (2003). Catalase superoxide dismutase and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg, 10, 309–15.
- Tamayo RP. (1983). Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? Hepatology, 3(1), 112–20.
- Tipoe GL, Leung TM, Liong EC, et al. (2010). Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology, 273(1–3), 45–52.
- Tsui JI, Pletcher MJ, Vittinghoff E, et al. (2006). Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol, 44(2), 262–6.
- Tsukamoto H, Matsuoka M, French SW. (1990). Experimental models of hepatic fibrosis: A review. Semin Liver Dis, 10(1), 56–65.
- Zhang S, Lu B, Han X, et al. (2013). Protection of the flavonoid fraction from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food Chem Toxicol, 55, 60–9.